Design Therapeutics, Inc. DSGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$17.64M+0.4% | -$16M-17.2% | -$17M-30.4% | -$19.08M-61.8% | -$17.72M-59.5% | ||
| $157K-1.3% | $156K+4.7% | $155K+1.3% | $152K+0.7% | $159K+11.2% | ||
| $3.92M+10.9% | $3.44M-1.0% | $3.59M+15.1% | $3.99M+20.8% | $3.54M+11.1% | ||
| -$2.51M-734% | $1.84M— | $2.41M— | $542K+175% | -$301K+88.1% | ||
| $287K-79.6% | $880K+245% | —— | —— | $1.41M+242% | ||
| -$16.43M+2.1% | -$11.97M-21.4% | -$11.16M-16.9% | -$14.44M-28.3% | -$16.79M-35.0% | ||
| $0-100% | $34K— | $0— | $87K-46.0% | $72K-63.1% | ||
| $52.59M-39.2% | $87.62M+36.1% | $78.08M+17.4% | $39.53M-26.3% | $86.55M+89.6% | ||
| $45M-52.4% | $76.08M+14.9% | $84.59M+39.4% | $59.74M-26.4% | $94.49M+42.2% | ||
| -$7.59M-196% | —— | $6.51M— | $20.12M-26.4% | $7.87M-61.8% | ||
| $19.91M— | $24.79M+91,904% | $37K+3,600% | $23K+283% | $0-100% | ||
| $19.93M+86,570% | $25.32M+9,526% | $37K+3,600% | $361K+57.6% | $23K+15.0% | ||
| -$4.09M+54.1% | —— | -$4.62M— | —— | -$8.9M-209% | ||
| $147K-86.1% | $512K-64.4% | $767K-47.3% | $914K-41.9% | $1.06M-38.8% | ||
| $157K-1.3% | $156K+4.7% | $155K+1.3% | $152K+0.7% | $159K+11.2% | ||
| -$2.51M-734% | $1.84M— | $2.41M— | $542K+175% | -$301K+88.1% | ||
| $287K-79.6% | $880K+245% | —— | —— | $1.41M+242% | ||
| $69K+1,825% | -$8K— | -$7K-800% | -$2K-150% | -$4K-200% | ||
| $45M-52.4% | $76.08M+14.9% | $84.59M+39.4% | $59.74M-26.4% | $94.49M+42.2% | ||
| $0-100% | —— | —— | —— | $54K— | ||
| —— | $4.25K— | $4.25K— | $4.25K— | $4.25K— | ||
| -$16.43M+2.6% | -$12M-21.7% | -$11.16M-17.1% | -$14.53M-27.2% | -$16.86M-33.5% | ||
| -$16.43M+2.6% | -$12M-21.7% | -$11.16M-17.1% | -$14.53M-27.2% | -$16.86M-33.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Design Therapeutics, Inc. generate?
- Design Therapeutics, Inc. (DSGN) generated -$54.0M in operating cash flow over the trailing twelve months.
- What is Design Therapeutics, Inc.'s free cash flow?
- After $121.0K of capital expenditures, Design Therapeutics, Inc.'s free cash flow was -$54.1M over the trailing twelve months, down 13.5% year over year.
- Where does Design Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Design Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.